Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-01 Sale | 2024-03-05 8:22 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 3,756 | $53.76 | $201,923 | 98,740 (Direct) | View |
| 2024-01-30 Sale | 2024-02-02 4:57 pm | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 11,931 | $13.14 | $156,733 | 31,243 (Direct) | View |
| 2023-05-04 Sale | 2023-05-05 2:16 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 4,378 | $45 | $197,010 | 51,982 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:59 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 3,161 | $45.25 | $143,035 | 95,539 (Direct) | View |
| 2022-03-07 Sale | 2022-03-08 12:25 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 5,140 | $62.95 | $323,563 | 34,438 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 6:08 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 2,886 | $66.62 | $192,265 | 64,478 (Direct) | View |
| 2021-10-14 Sale | 2021-10-18 6:46 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 310 | $81.14 | $25,153 | 28,358 (Direct) | View |
| 2021-09-08 Sale | 2021-09-09 6:22 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 7,336 | $100.65 | $738,368 | 46,332 (Direct) | View |
| 2021-06-10 Sale | 2021-06-11 9:08 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 1,329 | $100 | $132,900 | 28,668 (Direct) | View |
| 2021-05-06 Sale | 2021-05-10 6:13 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 313 | $113.67 | $35,579 | 29,997 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 8:47 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 3,970 | $138.17 | $548,535 | 41,227 (Direct) | View |
| 2020-10-30 Sale | 2020-11-02 5:05 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 9,903 | $100.12 | $991,488 | 49,061 (Direct) | View |
| 2020-10-28 Sale | 2020-10-30 5:28 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 97 | $100 | $9,700 | 58,871 (Direct) | View |
| 2020-10-14 Sale | 2020-10-16 7:21 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 325 | $88 | $28,600 | 23,968 (Direct) | View |
| 2020-10-08 Sale | 2020-10-13 5:53 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $95 | $950,000 | 59,293 (Direct) | View |
| 2020-10-06 Sale | 2020-10-07 2:57 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $90 | $900,000 | 41,293 (Direct) | View |
| 2020-09-23 Sale | 2020-09-24 4:47 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $85 | $850,000 | 51,293 (Direct) | View |
| 2020-08-17 Sale | 2020-08-19 2:12 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 12,370 | $88.43 | $1,093,884 | 69,293 (Direct) | View |
| 2020-05-18 Sale | 2020-05-19 7:12 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 2,722 | $74.72 | $203,374 | 27,312 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-05 8:22 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 50,157 | $0 | 98,740 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 6:37 pm | N/A 2034-02-07 | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 15,841 | $0 | 47,084 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-12 8:24 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 29,532 | $0 | 29,532 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:59 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 64,063 | $0 | 95,539 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 8:41 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 20,082 | $0 | 54,963 (Direct) | View |
| 2022-04-21 Option Award | 2022-10-03 7:56 pm | N/A 2027-02-28 | Anebulo Pharmaceuticals Inc. | ANEB | Parschauer Karah Herdman Director | 30,425 | $0 | 30,425 (Direct) | View |
| 2022-09-08 Option Award | 2022-09-09 7:25 pm | 2023-09-08 2032-09-07 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:08 pm | N/A 2032-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 38,900 | $0 | 64,478 (Direct) | View |
| 2022-01-24 Option Award | 2022-01-26 9:01 pm | N/A 2032-01-24 | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 38,295 | $0 | 57,608 (Direct) | View |
| 2021-12-22 Option Award | 2021-12-23 5:58 pm | N/A 2031-12-22 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 19,495 | $0 | 19,495 (Direct) | View |
| 2021-09-08 Exercise | 2021-09-09 6:22 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 7,336 | $54.5 | 46,332 (Direct) | View |
| 2021-09-08 Exercise | 2021-09-09 6:22 pm | N/A 2026-06-20 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 7,336 | $0 | 46,332 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-22 6:33 pm | N/A 2031-06-18 | Arcturus Therapeutics Holdings Inc. | ARCT | Parschauer Karah Herdman Director | 15,000 | $0 | 15,000 (Direct) | View |
Ownership | 2021-05-06 8:47 pm | N/A N/A | Anebulo Pharmaceuticals Inc. | ANEB | Parschauer Karah Herdman Director | 0 | $0 | 82,290 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 8:47 pm | N/A 2031-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 21,136 | $0 | 41,227 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 5:12 pm | N/A N/A | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 19,313 | $0 | 19,313 (Direct) | View |
| 2020-10-30 Exercise | 2020-11-02 5:05 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 9,903 | $54.5 | 49,061 (Direct) | View |
| 2020-10-30 Exercise | 2020-11-02 5:05 pm | N/A 2026-06-20 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 9,903 | $0 | 49,061 (Direct) | View |
| 2020-10-28 Exercise | 2020-10-30 5:28 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 97 | $54.5 | 58,871 (Direct) | View |
| 2020-10-28 Exercise | 2020-10-30 5:28 pm | N/A 2026-06-20 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 97 | $0 | 58,871 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-13 5:53 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $54.5 | 59,293 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-13 5:53 pm | N/A 2026-06-20 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $0 | 59,293 (Direct) | View |
| 2020-10-06 Exercise | 2020-10-07 2:57 pm | N/A 2028-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $0 | 41,293 (Direct) | View |
| 2020-10-06 Exercise | 2020-10-07 2:57 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $48.43 | 41,293 (Direct) | View |
| 2020-09-23 Exercise | 2020-09-24 4:47 pm | N/A 2028-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $0 | 51,293 (Direct) | View |
| 2020-09-23 Exercise | 2020-09-24 4:47 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $48.43 | 51,293 (Direct) | View |
| 2020-08-17 Exercise | 2020-08-19 2:12 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $54.5 | 69,293 (Direct) | View |
| 2020-08-17 Exercise | 2020-08-19 2:12 pm | N/A 2026-06-20 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 10,000 | $0 | 69,293 (Direct) | View |
| 2020-06-22 Option Award | 2020-06-24 8:02 pm | N/A 2030-06-21 | Arcturus Therapeutics Holdings Inc. | ARCT | Parschauer Karah Herdman Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-20 Tax Withholding | 2020-06-22 1:46 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 649 | $78.22 | 26,663 (Direct) | View |
| 2020-05-06 Tax Withholding | 2020-05-08 8:02 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 248 | $66.26 | 29,904 (Direct) | View |
| 2020-04-19 Tax Withholding | 2020-04-21 3:36 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 248 | $58.57 | 30,152 (Direct) | View |
| 2020-03-01 Option Award | 2020-03-03 8:00 pm | N/A 2030-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 35,434 | $0 | 52,400 (Direct) | View |
| 2020-03-01 Tax Withholding | 2020-03-03 8:00 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 2,118 | $56.08 | 52,400 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-24 9:06 pm | N/A 2030-01-23 | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 23,458 | $0 | 23,458 (Direct) | View |
| 2019-10-25 Option Award | 2019-10-29 8:40 pm | N/A 2029-10-24 | Arcturus Therapeutics Holdings Inc. | ARCT | Parschauer Karah Herdman Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2019-10-14 Option Award | 2019-10-16 7:28 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel | 1,434 | $0 | 19,084 (Direct) | View |
| 2019-07-15 Option Award | 2019-07-17 4:31 pm | N/A 2029-07-15 | Evolus Inc. | EOLS | Parschauer Karah Herdman Director | 26,163 | $0 | 26,163 (Direct) | View |